Market revenue in 2022 | USD 2.0 million |
Market revenue in 2030 | USD 6.9 million |
Growth rate | 16.6% (CAGR from 2022 to 2030) |
Largest segment | Solid-phase synthesis |
Fastest growing segment | PCR-based Enzyme Synthesis |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Solid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis |
Key market players worldwide | Genscript Biotech Corp Class H, Brooks Automation, Twist Bioscience Corp, ProteoGenix, Biomatik Corporation, Thermo Fisher Scientific Inc, Integrated DNA Technologies, Origene Technologies |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene synthesis market will help companies and investors design strategic landscapes.
Solid-phase synthesis was the largest segment with a revenue share of 35% in 2022. Horizon Databook has segmented the Saudi Arabia gene synthesis market based on solid-phase synthesis, chip-based synthesis, pcr-based enzyme synthesis covering the revenue growth of each sub-segment from 2018 to 2030.
In recent years, the Kingdom of Saudi Arabia has been focusing on economic diversification and has been the third-fastest growing economy in the world over the past 5 decades, only behind China and South Korea. With strategic frameworks such as Vision 2030, the kingdom is anticipated to make significant investments in recent and evolving technologies, especially biological technologies.
For instance, in September 2021, the kingdom hosted the Riyadh Global Medical Biotechnology Summit and expressed its intentions to become a regional hub for biotechnology development. Such initiatives are driving penetration of biotechnological applications in the kingdom and are expected to contribute to market growth.
Furthermore, organizations such as SaudiVax are focusing on building a biotechnology ecosystem by providing access to specialized facilities, as well as R&D and educational support in this domain. The organization also partnered with Merck in February 2022 for building a manufacturing facility, which can increase gene therapy access for patients in the region.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia gene synthesis market, including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia gene synthesis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account